Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Piperacillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Tazobactam is a beta-lactamase inhibitor that protects piperacillin from degradation by beta-lactamases.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
3.375 g (piperacillin 3 g / tazobactam 0.375 g) IV every 6 hours for 7-10 days; extended infusion dosing: 3.375 g IV over 4 hours every 8 hours.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Piperacillin: 0.7-1.2 hours (normal renal function), extends to 2-6 hours in renal impairment; Tazobactam: 0.8-1.2 hours (normal renal function), extends to 4-8 hours in severe renal impairment; clinically relevant for dosing interval adjustments in renal dysfunction.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Piperacillin: ~70-80% renal (glomerular filtration and tubular secretion), ~10-20% biliary; Tazobactam: ~80-85% renal, ~10% biliary; both primarily excreted unchanged in urine; small fecal elimination (<5%).
Category C
Category A/B
Electrolyte
Electrolyte